Fulgent Genetics, Inc. (FLGT) Misses Q3 EPS by 11c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $0.06, $0.11 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $105.66 million versus the consensus estimate of $103.7 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• UBS Downgrades Grand Korea Leisure (114090:KS) to Neutral
• SOL Strategies files amended Q2 fiscal 2026 interim financials